Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-01-04 @ 5:15 PM
Study NCT ID:
NCT02822157
Status:
UNKNOWN
Last Update Posted:
2021-01-29
First Post:
2016-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08
Start Date Type:
None
Primary Completion Date:
2021-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-07
Completion Date Type:
ESTIMATED
First Submit Date:
2016-06-06
First Submit QC Date:
None
Study First Post Date:
2016-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-26
Last Update Post Date:
2021-01-29
Last Update Post Date Type:
ACTUAL